Faslodex (fulvestrant) 250 mg/5 ml is a targeted hormone therapy for the treatment of specific cancers. Manufactured by AstraZeneca.
EGP 10,330
Based on 0 reviews
You can add a rating once you purchase the product through the My Orders page